The PCA3-Cre-PSEBC-ITSTA system, which is based on combinational activation of two prostate cancer gene promoters, has the ability to study dynamic and quantitative antiandrogen single-cell response from urine and primary cancer tissues harvested from PCa patients. The gene discussed is PCA3; the disease is Familial prostate cancer.